At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Market Closed 12-20 16:00:00 EST
33.60
+0.17
+0.51%
盘后33.74
+0.14+0.42%
19:02 EST
High33.87Low33.04Vol6.81M
Open33.14D1 Closing33.43Amplitude2.48%
Mkt Cap68.55BTradable Cap67.47BTotal Shares2.04B
T/O228.98MT/O Rate0.34%Tradable Shares2.01B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold?
Zacks  ·  12-21 02:00
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold?
Ionis Gets FDA Approval for Rare Disease Drug Tryngolza
Zacks  ·  12-20 21:03
Ionis Gets FDA Approval for Rare Disease Drug Tryngolza
GSK's Trial Evaluating Zejula, Jemperli Meets Primary Endpoint for Ovarian Cancer Treatment
MT Newswires Live  ·  12-20 19:56
GSK's Trial Evaluating Zejula, Jemperli Meets Primary Endpoint for Ovarian Cancer Treatment
GSK announces FIRST advanced ovarian cancer trial met primary endpoint
TIPRANKS  ·  12-20 19:30
GSK announces FIRST advanced ovarian cancer trial met primary endpoint
GSK Hits Key Milestone in Ovarian Cancer Trial
TIPRANKS  ·  12-20 18:16
GSK Hits Key Milestone in Ovarian Cancer Trial
GSK Initiates Block Listing for 700,000 Shares
TIPRANKS  ·  12-20 17:02
GSK Initiates Block Listing for 700,000 Shares
GlaxoSmithKline (GSK) Gets a Hold from Goldman Sachs
TIPRANKS  ·  12-20
GlaxoSmithKline (GSK) Gets a Hold from Goldman Sachs
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains
Zacks  ·  12-18
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Blockhead  ·  12-18
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
Business Wire  ·  12-18
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?
Blockhead  ·  12-17
AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
Zacks  ·  12-17
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
GSK’s ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria
TIPRANKS  ·  12-16
GSK’s ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria
GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer
MT Newswires Live  ·  12-16
GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer
GSK announces EMA granted PRIME Designation for GSK5764227
TIPRANKS  ·  12-16
GSK announces EMA granted PRIME Designation for GSK5764227
GSK announces CHMP of the EMA recommended expanding approval of Jemperli
TIPRANKS  ·  12-16
GSK announces CHMP of the EMA recommended expanding approval of Jemperli
GSK announces FDA granted BTD for Jemperli
TIPRANKS  ·  12-16
GSK announces FDA granted BTD for Jemperli
GSK's Cancer Drug Jemperli Nears EU Marketing Expansion -- 2nd Update
Dow Jones  ·  12-16
GSK's Cancer Drug Jemperli Nears EU Marketing Expansion -- 2nd Update
GSK’s Jemperli Receives Breakthrough Therapy Designation from FDA
TIPRANKS  ·  12-16
GSK’s Jemperli Receives Breakthrough Therapy Designation from FDA
GSK’s GSK’227 Receives PRIME Designation for Lung Cancer Treatment
TIPRANKS  ·  12-16
GSK’s GSK’227 Receives PRIME Designation for Lung Cancer Treatment

Introduction

Company Name.
GlaxoSmithKline PLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--